Proton Magnetic Resonance Spectroscopy at 3T-Evaluation of Metabolic Profile of Human Brain Lesions

被引:0
作者
Kousi, E. [1 ]
Tsougos, I. [1 ]
Kapsalaki, E. [2 ]
Kappas, C. [1 ]
Theodorou, K. [1 ]
机构
[1] Univ Thessaly, Sch Med, Dept Med Phys, Larisa, Greece
[2] Univ Thessaly, Sch Med, Dept Diagnost Radiol, Larisa, Greece
来源
WORLD CONGRESS ON MEDICAL PHYSICS AND BIOMEDICAL ENGINEERING, VOL 25, PT 2 - DIAGNOSTIC IMAGING | 2009年 / 25卷
关键词
MRS; 3T; Metabolic profile; brain lesions; MR SPECTROSCOPY; TUMORS;
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Brain MR imaging at 3T has been increasingly used in clinical practice since a great deal of effort has been invested in research into high magnetic fields to overcome the difficulties of successively working with stronger fields. Theoretically the signal to noise ratio (SNR) of a 3T MR scanner will be double that of a 1.5T one which is advantageous for MR spectroscopy as this technique has always required the strongest possible magnetic field strength. However, the relationship between the magnetic field used and the spectra obtained is very complex depended on several other data acquisition parameters not only field strength. Single-voxel at short echo time (TE=35msec) and multivoxel at long echo time (TE=144msec) spectra were recorded for 46 patients with several brain lesions using PRESS pulse sequence. Spectra were compared in terms of resolution as it varies among changes of data acquisition parameters such as NEX (Number of Excitations), NSA (Number of Signals Averaging) and field homogeneity. Spectra exhibited significantly improved resolution as field homogeneity was improved and NEX as well as NSA were increased. MRS metabolic profiles at 3T gave valuable clinical information when differentiating among brain lesions and tumour stages. However, in some cases, differences among tumour grade and lesion type were subtle, rendering tumour classification a difficult issue.
引用
收藏
页码:335 / 337
页数:3
相关论文
共 10 条
[1]  
Castillo M, 2000, AM J NEURORADIOL, V21, P1645
[2]  
Davila J., 2008, EUR J RADIOL
[3]   In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases [J].
Fan, G ;
Sun, B ;
Wu, Z ;
Guo, Q ;
Guo,Y .
CLINICAL RADIOLOGY, 2004, 59 (01) :77-85
[4]   High-resolution 3D proton spectroscopic imaging of the human brain at 3 T:: SNR issues and application for anatomy-matched voxel sizes [J].
Gruber, S ;
Mlynárik, V ;
Moser, E .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (02) :299-306
[5]   The principles of quantification applied to in vivo proton MR spectroscopy [J].
Helms, Gunther .
EUROPEAN JOURNAL OF RADIOLOGY, 2008, 67 (02) :218-229
[6]   1H MR spectroscopy of brain tumours and masses [J].
Howe, FA ;
Opstad, KS .
NMR IN BIOMEDICINE, 2003, 16 (03) :123-131
[7]   Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy [J].
Howe, FA ;
Barton, SJ ;
Cudlip, SA ;
Stubbs, M ;
Saunders, DE ;
Murphy, M ;
Wilkins, P ;
Opstad, KS ;
Doyle, VL ;
McLean, MA ;
Bell, BA ;
Griffiths, JR .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (02) :223-232
[8]  
Majós C, 2004, AM J NEURORADIOL, V25, P1696
[9]  
Ricci PE, 2000, AM J NEURORADIOL, V21, P367
[10]   Magnetic resonance spectroscopy of the brain: review of metabolites and clinical applications [J].
Soares, D. P. ;
Law, M. .
CLINICAL RADIOLOGY, 2009, 64 (01) :12-21